
Sponsored Content
Oral administration of small molecules has become increasingly difficult due to a majority of new candidates demonstrating poor aqueous solubility. Dr. David Lyon will discuss a proven model-based technology selection methodology for poorly soluble molecules and an integrated formulation approach to minimize first-in-human timelines. Live: Wednesday, Oct. 23, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Oct. 23, 2020 Register free